The novel agent, alpha lipoic acid, can cause the development of insulin autoimmune syndrome

Internal Medicine

Volumn 46, Issue 17, 2007, Pages 1321-1322

  Uchigata, Yasuko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Health supplements; Insulin autoimmune syndrome; Novel agent

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CAPTOPRIL; HLA DR ANTIGEN; IMIPENEM; INSULIN; INSULIN ANTIBODY; PENICILLIN G; RETINOL; RIBOFLAVIN; THIOCTIC ACID; ANTIOXIDANT; AUTOANTIBODY;

ANTIBODY PRODUCTION; ANTIOXIDANT ACTIVITY; AUTOIMMUNE DISEASE; DIABETIC NEUROPATHY; DIET SUPPLEMENTATION; DISEASE PREDISPOSITION; DRUG INDUCED DISEASE; EDITORIAL; HEARING DISORDER; HUMAN; HYPOGLYCEMIA; INSULIN AUTOIMMUNE SYNDROME; INSULIN BLOOD LEVEL; LEIGH DISEASE; PATHOGENESIS; CHEMICALLY INDUCED DISORDER; GENETICS; IMMUNOLOGY;

ANTIOXIDANTS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; HUMANS; HYPOGLYCEMIA; INSULIN; THIOCTIC ACID;

EID: 34548778163     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.0221     Document Type: Editorial

References (10)

1. Takeuchi Y, Miyamoto T, Kakizawa T, Shigematsu S, Hashizume K. Insulin autoimmune syndrome possibly caused by alpha lipoic acid. Intern Med 46: 237-239, 2007.
2. Smith AR, Shenvi SV, Widlansky M, Suh JH, Hagen TM. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr Med Chem 11: 1135-1146, 2004.
3. Pick U, Haramaki N, Constantinescu A, Handelman GJ, Tritschler HJ, Packer L. Glutathione reductase and lipoamide dehydrogenease have opposite atereospecifities for alpha lipoic acid enantiomers. Biochem Biophys Res Commun 206: 724-730, 2005.
4. Hirata Y, Ishizu H, Ouchi N, et al. Insulin autoimmunity in a case of spontaneous hypo-glycemia. J Jpn Diabetes Soc 13: 312-320, 1970 (in Japanese).
5. Uchigata Y, Kuwata S, Tokunaga K, et al. Strong association of insulin autoimmune syndrome with HLA-DR4. Lancet 339: 393-394, 1992.
6. Uchigata Y, Eguchi Y, Takayama-Hasumi S, Omon Y. Insulin autoimmune syndrome (Hirata Disease); clinical features and epidemiology. Diab Res Clin Pract 22: 89-94, 1994.
7. Uchigata Y, Tokunaga K, Nepom G, et al. Differential immunologic determinants of polyclonal insulin autoinumme syndrome (Hirata's Disease) and monoclonal insulin autoimmune syndrome. Diabetes 44: 1227-1232, 1995.
8. Lidar M, Rachmani R, Half E, Ravid M. Insulin aufiimmune syndrome after therapy with imipenem. Diabetes Care 22: 524-525, 1999.
9. Cavaco, B, Uchigata Y, Porto T, Amparo-Santos M, Sobrinho L, Leite V. Hypoglycaemia due to insulin autoiimune syndrome: report of two cases with characterisation of HLA alleles and insulin autoiantibodies. Eur J Endocrinol 145: 311-316, 2001.
10. Matsushita S, Takahashi K, Motoki M, Komoriya K, Ikagawa S, Nishimura Y. Allele specificity of structural requirement for peptide bound to HLA-DRB1*0405 and DRB1*0406 complex: Implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J Exp Med 180: 873-883, 1994.